Sanofi (SNY) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 100.67B |
| Enterprise Value | 114.8B |
| P/E Ratio | 8.87 |
| PEG Ratio | -0.74 |
| Price/Sales Ratio | 1.56 |
| Price/Book Ratio | 1.26 |
| Enterprise/Revenue | 1.8 |
| Enterprise/EBITDA | 9.76 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.18 |
| Operating Margin | 0.25 |
AD
Management Effectiveness
| Return On Assets | 0.08 |
| Return On Equity | 0.14 |
Income Statement
| Revenue | 46.72B |
| Revenue/Share | 48.9 |
| Gross Profit | 33.67B |
| EBITDA | 12.48B |
| Net Income | 7.81B |
| Diluted EPS | 3.2 |
Balance Sheet
| Total Cash | 5.54B |
| Total Cash/Share | 4.6 |
| Total Debt | 20.02B |
| Total Debt/Equity | 0.27 |
| Current Ratio | 1.01 |
| Book Value Per Share | 60.74 |
Price History
| 52-Week Change | -11.25 |
| 52-Week High | 52.68 |
| 52-Week Low | 42.28 |
| Moving Average 50 Days | 45.24 |
| Moving Average 200 Days | 47.34 |
Statistics
| Average Volume | 2.87M |
| Shares Outstanding | 2.4B |
| % Held by Institutions | 8.6 |
Dividend And Splits
| Trailing Annual Dividend Rate | 4.12 |
| Trailing Annual Dividend Yield | 5.4 |
| Payout Ratio | 0.46 |
| Last Split Factor | 5:1 |
| Last Split Date | September 30, 2013 |
AD
